SEVERANCE AGREEMENTSeverance Agreement • March 8th, 2022 • Aeglea BioTherapeutics, Inc. • Pharmaceutical preparations • Texas
Contract Type FiledMarch 8th, 2022 Company Industry JurisdictionThis Severance Agreement (the “Agreement”) is entered into as of July 6, 2021 (the “Effective Date”) by and between Jonathan Alspaugh (the “Executive”) and Aeglea BioTherapeutics, Inc., a Delaware corporation (the “Company”).